Company / Cash per Share
MAXCYTE, INC. Cash per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.19
FY2025
5-year range
$0.11 / $0.62
FY2021-FY2025
Trend
-29.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.45 to $0.19 over the past 2 years.
Based on SEC 10-K filings.
0.19 in FY2025 with a 3-year CAGR of +20.2%.
Declined from $0.45 to $0.19 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +20.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 29.2% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -29.2% |
| FY2024 | $0.27 | -40.9% |
| FY2023 | $0.45 | +315.4% |
| FY2022 | $0.11 | -82.3% |
| FY2021 | $0.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026